Business Description
AP Biosciences Inc
ISIN : TW0006945009
Description
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.02 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.25 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 21.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 187.3 | |||||
| 3-Year FCF Growth Rate | -987.4 | |||||
| 3-Year Book Growth Rate | 396.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.99 | |||||
| 9-Day RSI | 51.47 | |||||
| 14-Day RSI | 50.69 | |||||
| 6-1 Month Momentum % | 14.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 24.8 | |||||
| Quick Ratio | 24.8 | |||||
| Cash Ratio | 23.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -115.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1077.35 | |||||
| Net Margin % | -1051.98 | |||||
| FCF Margin % | -1032.55 | |||||
| ROE % | -35.4 | |||||
| ROA % | -32.91 | |||||
| ROIC % | -378.64 | |||||
| ROC (Joel Greenblatt) % | -448.17 | |||||
| ROCE % | -33.44 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 120.88 | |||||
| PB Ratio | 4.97 | |||||
| Price-to-Tangible-Book | 5 | |||||
| EV-to-EBIT | -9.61 | |||||
| EV-to-EBITDA | -9.98 | |||||
| EV-to-Revenue | 100.69 | |||||
| EV-to-FCF | -9.65 | |||||
| Price-to-Net-Current-Asset-Value | 5.91 | |||||
| Price-to-Net-Cash | 6.16 | |||||
| Earnings Yield (Greenblatt) % | -10.41 | |||||
| FCF Yield % | -8.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AP Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 32.253 | ||
| EPS (TTM) (NT$) | -5.24 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 50.69 | ||
| 14-Day ATR (NT$) | 1.334158 | ||
| 20-Day SMA (NT$) | 60.295 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 41.05 - 84.2 | ||
| Shares Outstanding (Mil) | 64.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AP Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AP Biosciences Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
AP Biosciences Inc Frequently Asked Questions
What is AP Biosciences Inc(ROCO:6945)'s stock price today?
The current price of ROCO:6945 is NT$60.20. The 52 week high of ROCO:6945 is NT$84.20 and 52 week low is NT$41.05.
When is next earnings date of AP Biosciences Inc(ROCO:6945)?
The next earnings date of AP Biosciences Inc(ROCO:6945) is .
Does AP Biosciences Inc(ROCO:6945) pay dividends? If so, how much?
AP Biosciences Inc(ROCO:6945) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers